Prevalence of Vitamin D deficiency and association with metabolic syndrome in a Qatari population

Nutrition and Diabetes

Volumn 7, Issue 4, 2017, Pages

  Al Dabhani, K ^a   Tsilidis, K K ^a,b   Murphy, N ^a,c   Ward, H A ^a   Elliott, P ^a   Riboli, E ^a   Gunter, M ^c   Tzoulaki, I ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF IOANNINA   (Greece)

^c Nutritional Epidemiology Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D;

ADULT; AGED; ARTICLE; BIOBANK; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QATARI; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; ADOLESCENT; BLOOD; COMPLICATION; MIDDLE AGED; QATAR; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME; MIDDLE AGED; PREVALENCE; QATAR; SEX FACTORS; TRIGLYCERIDES; VITAMIN D; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 85017402977     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2017.14     Document Type: Article

References (56)

1. Hossein-Nezhad A, Holick MF. Vitamin D for health: A global perspective. Mayo Clin Proc 2015; 88: 720-755.
2. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JPA. Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014; 348: 2035.
3. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
4. Lips P. Relative value of 25(OH)D and 1, 25(OH)2D measurements. J Bone Miner Res 2007; 22: 1668-1671.
5. Sharifi F, Mousavinasab N, Mellati AA. Defining a cutoff point for vitamin D deficiency based on insulin resistance in children. Diabetes Metab Syndr Netherlands 2013; 7: 210-213.
6. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Optimal vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am J Prev Med 2007; 32: 210-216.
7. Dawson-Hughes B, Heaney RP, Holick M, Lips P, Meunier PJ, Vieth R. Vitamin D round table. In: Burckhardt P, Dawson-Hughes B, Heaney R (eds). Nutritional Aspects of Osteoporosis, 2nd edn. Elsiever, Inc. : San Diego, CA, USA, 2004, pp 263-270.
8. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106: 963-968.
9. Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: Results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 2012; 55: 2173-2182.
10. Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett WC, Hankinson SE. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res 2011; 13: R50.
11. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011; 128: 1414-1424.
12. Kayaniyil S, Harris SB, Retnakaran R, Vieth R, Knight JA, Gerstein HC, et al. Prospective association of 25(OH)D with metabolic syndrome. Clin Endocrinol 2014; 80: 502-507.
13. Lu Y, Liu M, Pei Y, Li J, Tian H, Cheng X, et al. Low levels of serum 25-hydroxyvitamin D and risk of metabolic syndrome in China. Int J Clin Exp Med 2015; 8: 13790-13796.
14. Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: A systematic review and meta-analysis of prospective studies. Proc Nutr Soc 2013; 72: 89-97.
15. Fung GJ, Steffen LM, Zhou X, Harnack L, Tang W, Lutsey PL, et al. Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20 y: The coronary artery risk development in young adults study. Am J Clin Nutr 2012; 96: 24-29.
16. Vitezova A, Zillikens MC, van Herpt TTW, Sijbrands EJG, Hofman A, Uitterlinden AG, et al. Vitamin D status and metabolic syndrome in the elderly: The Rotterdam Study. Eur J Endocrinol 2015; 172: 327-335.
17. Amirbaigloo A, Hosseinpanah F, Sarvghadi F, Tohidi M, Eskandary PS, Azizi F. Absence of association between vitamin D deficiency and incident metabolic syndrome: Tehran Lipid and Glucose Study. Metab Syndr Relat Disord 2013; 11: 236-242.
18. Chon SJ, Yun BH, Jung YS, Cho SH, Choi YS, Kim SY, et al. Association between vitamin D status and risk of metabolic syndrome among Korean postmenopausal women. PLoS One 2014; 9: E89721.
19. Pekkanen MP, Ukkola O, Hedberg P, Piira OP, Lepojärvi S, Lumme J, et al. Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 2015; 25; 471-478.
20. Park HY, Lim Y-H, Kim JH, Bae S, Oh S-Y, Hong Y-C. Association of serum 25-hydroxyvitamin D levels with markers for metabolic syndrome in the elderly: A repeated measure analysis. J Korean Med Sci 2012; 27: 653-660.
21. Golbahar J, Al-Saffar N, Altayab Diab D, Al-Othman S, Darwish A, Al-Kafaji G. Predictors of vitamin D deficiency and insufficiency in adult Bahrainis: A crosssectional study. Public Health Nutr 2014; 17: 732-738.
22. Alhamad HK, Nadukkandiyil N, El-Menyar A, Abdel Wahab L, Sankaranarayanan A, Al Sulaiti EM. Vitamin D deficiency among the elderly: Insights from Qatar. Curr Med Res Opin 2014; 30: 1189-1196.
23. Hussain A, Alkhenizan A, El Shaker M, Raef H, Gabr A. Increasing trends and significance of hypovitaminosis D: A population-based study in the Kingdom of Saudi Arabia. Arch Osteoporos 2014; 9: 1-5.
24. Alyahya K, Lee WTK, Al-Mazidi Z, Morgan J, Lanham-New S. Risk factors of low vitamin D status in adolescent females in Kuwait: Implications for high peak bone mass attainment. Arch Osteoporos 2014; 9: 178.
25. Sadiya A, Ahmed SM, Skaria S, Abusnana S. Vitamin D status and its relationship with metabolic markers in persons with obesity and type 2 diabetes in the UAE: A cross-sectional study. J Diabetes Res 2014; 2014: 869307.
26. Mahdy S, Al-Emadi SA, Khanjar IA, Hammoudeh MM, Sarakbi HA, Siam AM, et al. Vitamin D status in health care professionals in Qatar. Saudi Med J 2010; 31: 74-77.
27. Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AOAA. Prevalence of metabolic syndrome according to adult treatment panel iii and international diabetes federation criteria: A population-based study. Metab Syndr Relat Disord 2009; 7: 221-230.
28. Al Zenki S, Al Omirah H, Al Hooti S, Al Hamad N, Jackson RT, Rao A, et al. High prevalence of metabolic syndrome among Kuwaiti adults-a wake-up call for public health intervention. Int J Environ Res Public Health 2012; 9: 1984-1996.
29. Al-Lawati JA, Jousilahti P. Prevalence of metabolic syndrome in Oman using the International Diabetes Federation's Criteria. Saudi Med J 2006; 27: 1925-1926.
30. Hajat C, Shather Z. Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population. Diabetes Res Clin Pract 2012; 98: 481-486.
31. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Sabico SLB, Chrousos GP. Decreasing prevalence of the full metabolic syndrome but a persistently high prevalence of dyslipidemia among adult Arabs. PLoS ONE 2010; 5: E12159.
32. Al Kuwari H, Al Thani A, Al Marri A, Al Kaabi A, Abderrahim H, Afifi N, et al. The Qatar Biobank: Background and methods. BMC Public Health 2015; 15: 1-9.
33. Holick MF, Bischoff-Ferrari H, Gordon C, Hanley D. Guidelines evaluation, treatment, and prevention of Vitamin D deficiency. J Clin Endocrinol Metab 2011; 96: 1911-1930.
34. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [Internet]. The IDF consensus worldwide definition of the metabolic syndrome. 2006; pp 1-7. Available at: Http://www. idf. org/webdata/docs/MetS-def-update2006. pdf.
35. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care; 38(Suppl 1): S8-16. Available at: Http://care. diabetesjournals. org/content/38/Supplement-1/S8. short.
36. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-511.
37. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29: 650-666.
38. McKibben RA, Zhao D, Lutsey PL, Schneider ALC, Guallar E, Mosley TH, et al. Factors associated with change in 25-hydroxyvitamin D Levels Over longitudinal follow-up in the ARIC study. J Clin Endocrinol Metab 2015; 101: 33-43.
39. Hoteit M, Al-Shaar L, Yazbeck C, Bou Sleiman M, Ghalayini T, Fuleihan GE-H. Hypovitaminosis D in a sunny country: Time trends, predictors, and implications for practice guidelines. Metabolism 2014; 63: 968-978.
40. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: Results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012; 97: 1953-1961.
41. Reis JP, von Mühlen D, Miller ER. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008; 159: 41-48.
42. Maki KC, Fulgoni VL, Keast DR, Rains TM, Park KM, Rubin MR. Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U. S. Adults: National health and nutrition examination surveys 2003-2006. Metab Syndr Relat Disord 2012; 10: 363-372.
43. Vitezova A, Voortman T, Zillikens MC, Jansen PW, Hofman A, Uitterlinden AG, et al. Bidirectional associations between circulating Vitamin D and cholesterol levels: The Rotterdam Study. Maturitas 2015; 82: 411-417.
44. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Causal relationship between obesity and Vitamin D status: Bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013; 10: E1001383.
45. Majumdar V, Nagaraja D, Christopher R. Vitamin D status and metabolic syndrome in Asian Indians. Int J Obes 2011; 35: 1131-1134.
46. Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007; 30: 1549-1555.
47. Hyppönen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age A cross-sectional study in the 1958 british birth cohort. Diabetes 2008; 57: 298-305.
48. Zhang M, Li P, Zhu Y, Chang H, Wang X, Liu W, et al. Higher visceral fat area increases the risk of vitamin D insufficiency and deficiency in Chinese adults. Nutr Metab 2015; 12: 50.
49. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
50. Awad AB, Alappat L, Valerio M. Vitamin D and Metabolic syndrome risk factors: Evidence and mechanisms. Crit Rev Food Sci Nutr 2012; 52: 103-112.
51. Ardawi M-SM, Sibiany AM, Bakhsh TM, Qari MH, Maimani AA. High prevalence of vitamin D deficiency among healthy Saudi Arabian men: Relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Osteoporos Int 2011; 23: 675-686.
52. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32: 1278-1283.
53. Moy F-M, Bulgiba A. High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia. BMC Public Health 2011; 11: 1-7.
54. Oosterwerff MM, Eekhoff EMW, Heymans MW, Lips P, van Schoor NM. Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: A population-based study. Clin Endocrinol 2011; 75: 608-613.
55. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum Vitamin D and the metabolic syndrome among U. S. adults. Diabetes Care 2005; 28: 1228-1230.
56. World Health Organization. Qatar Stepwise Report. 2012. Available at: Http://www. who. int/chp/steps/Qatar-2012-STEPwise-Report. pdf?ua = 1.